Biotechnology News HYCAMTIN Search

BioNews
Biotechnology, Pharmaceutical, Life Science & Medical News
Track this topic with BioWatch News Alerts: Register | Login

Search Results

Documents 1-6 out of 6 found

Current Search: hycamtin: 6

Poniard Pharmaceuticals: Platinum Rediscovered (Part II)
This article will discuss the development of Poniards lead drug, picoplatin, for the treatment of small cell lung cancer [SCLC].

A General introduction for picoplatin can be found in the first part of this article.

As a novel platinum...

Seeking Alpha: Jun 24 2008 3:44PM
Matching: hycamtin

Find similar documents

Treatment Can Make Cancer Stronger
But New Cancer Treatment 'Revolution' Under Way WebMD Medical News Reviewed By Louise Chang, MD June 10, 2008 What doesn't kill cancer cells makes them stronger, Duke researchers have observed.

Doctors use radiation and chemotherapy to...

eMedicine Health: Jun 12 2008 4:14AM
Matching: hycamtin

Find similar documents

Glaxo's Hycamtin Shows No Benefit In 1st-Line Ovarian Cancer
Of DOW JONES NEWSWIRES CHICAGO -(Dow Jones)- A drug regimen that included GlaxoSmithKline PLC's (GSK) Hycamtin didn't delay progression of ovarian cancer compared with another treatment, and was more toxic, a new study found.

...

Lloyd's: Jun 2 2008 2:44AM
Matching: hycamtin

Find similar documents

Glaxo's Hycamtin Shows No Benefit In 1st-Line Ovarian Cancer
CHICAGO Women with previously untreated epithelial ovarian cancer are typically treated with a chemotherapy combination of carboplatin and paclitaxel.

Researchers tested whether giving a combination of Hycamtin and cisplatin,...

Morningstar.com: Jun 1 2008 11:00PM
Matching: hycamtin

Find similar documents

ASCO AT A GLANCE: Genetic Research A Focus Of Cancer Meeting
THE EVENT: Thousands of cancer specialists are in Chicago this week attending the 44th annual meeting of the American Society of Clinical Oncology, where pharmaceutical and biotech companies are providing updates on 4,200 studies.

The five...

Lloyd's: Jun 2 2008 8:16AM
Matching: hycamtin

Find similar documents

GlaxoSmithKline Receives Authorisation in Europe for Oral Hycamtin for the Treatment of Relapsed Small Cell Lu
New oral single-agent chemotherapy approved for the treatment of patients with relapsed small cell lung cancer (SCLC) for whom re-treatment with the first-line regimen is not considered appropriate LONDON, April 12, 2008-GlaxoSmithKline (GSK...

Pharma Live: May 12 2008 3:36PM
Matching: hycamtin

Find similar documents

Home Marketing Services News Reports Company Profiles InDepth Drug Discovery Careers Conferences Videos Search Contact
	Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner. See User Agreement Send comments and feedback to: Peter Barfoot Managing Director, BioPortfolio Ltd. UK Tel: (+44) 1300 321501 USA Voicemail and Fax: (+1) 415 680 2472	All rights reserved. All other trademarks recognized. BioPortfolio Limited is registered in England & Wales at Wessex Barn, Dorchester Road, Frampton, Dorset, DT2 9NB, UK. No.3312883 VAT No. GB 744 6483 10 Copyright � 1997-2008 - BioPortfolio Limited.